RAS mutations drive proliferative chronic myelomonocytic leukemia via a KMT2A-PLK1 axis

Chronic myelomonocytic leukaemia is classified as proliferative (pCMML) or dysplastic based on the white blood cell counts but biological differences are unclear. Here, the authors show genetic, transcriptomic and epigenomic differences between these two subtypes establishing that pCMML is RAS-pathw...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ryan M. Carr, Denis Vorobyev, Terra Lasho, David L. Marks, Ezequiel J. Tolosa, Alexis Vedder, Luciana L. Almada, Andrey Yurcheko, Ismael Padioleau, Bonnie Alver, Giacomo Coltro, Moritz Binder, Stephanie L. Safgren, Isaac Horn, Xiaona You, Eric Solary, Maria E. Balasis, Kurt Berger, James Hiebert, Thomas Witzig, Ajinkya Buradkar, Temeida Graf, Peter Valent, Abhishek A. Mangaonkar, Keith D. Robertson, Matthew T. Howard, Scott H. Kaufmann, Christopher Pin, Martin E. Fernandez-Zapico, Klaus Geissler, Nathalie Droin, Eric Padron, Jing Zhang, Sergey Nikolaev, Mrinal M. Patnaik
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Q
Acceso en línea:https://doaj.org/article/76c77b395be34b1d8dcd36a45fbde44e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:76c77b395be34b1d8dcd36a45fbde44e
record_format dspace
spelling oai:doaj.org-article:76c77b395be34b1d8dcd36a45fbde44e2021-12-02T16:51:30ZRAS mutations drive proliferative chronic myelomonocytic leukemia via a KMT2A-PLK1 axis10.1038/s41467-021-23186-w2041-1723https://doaj.org/article/76c77b395be34b1d8dcd36a45fbde44e2021-05-01T00:00:00Zhttps://doi.org/10.1038/s41467-021-23186-whttps://doaj.org/toc/2041-1723Chronic myelomonocytic leukaemia is classified as proliferative (pCMML) or dysplastic based on the white blood cell counts but biological differences are unclear. Here, the authors show genetic, transcriptomic and epigenomic differences between these two subtypes establishing that pCMML is RAS-pathway driven and that inhibiting RAS-driven PLK1 expression is a viable therapeutic target.Ryan M. CarrDenis VorobyevTerra LashoDavid L. MarksEzequiel J. TolosaAlexis VedderLuciana L. AlmadaAndrey YurchekoIsmael PadioleauBonnie AlverGiacomo ColtroMoritz BinderStephanie L. SafgrenIsaac HornXiaona YouEric SolaryMaria E. BalasisKurt BergerJames HiebertThomas WitzigAjinkya BuradkarTemeida GrafPeter ValentAbhishek A. MangaonkarKeith D. RobertsonMatthew T. HowardScott H. KaufmannChristopher PinMartin E. Fernandez-ZapicoKlaus GeisslerNathalie DroinEric PadronJing ZhangSergey NikolaevMrinal M. PatnaikNature PortfolioarticleScienceQENNature Communications, Vol 12, Iss 1, Pp 1-18 (2021)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Ryan M. Carr
Denis Vorobyev
Terra Lasho
David L. Marks
Ezequiel J. Tolosa
Alexis Vedder
Luciana L. Almada
Andrey Yurcheko
Ismael Padioleau
Bonnie Alver
Giacomo Coltro
Moritz Binder
Stephanie L. Safgren
Isaac Horn
Xiaona You
Eric Solary
Maria E. Balasis
Kurt Berger
James Hiebert
Thomas Witzig
Ajinkya Buradkar
Temeida Graf
Peter Valent
Abhishek A. Mangaonkar
Keith D. Robertson
Matthew T. Howard
Scott H. Kaufmann
Christopher Pin
Martin E. Fernandez-Zapico
Klaus Geissler
Nathalie Droin
Eric Padron
Jing Zhang
Sergey Nikolaev
Mrinal M. Patnaik
RAS mutations drive proliferative chronic myelomonocytic leukemia via a KMT2A-PLK1 axis
description Chronic myelomonocytic leukaemia is classified as proliferative (pCMML) or dysplastic based on the white blood cell counts but biological differences are unclear. Here, the authors show genetic, transcriptomic and epigenomic differences between these two subtypes establishing that pCMML is RAS-pathway driven and that inhibiting RAS-driven PLK1 expression is a viable therapeutic target.
format article
author Ryan M. Carr
Denis Vorobyev
Terra Lasho
David L. Marks
Ezequiel J. Tolosa
Alexis Vedder
Luciana L. Almada
Andrey Yurcheko
Ismael Padioleau
Bonnie Alver
Giacomo Coltro
Moritz Binder
Stephanie L. Safgren
Isaac Horn
Xiaona You
Eric Solary
Maria E. Balasis
Kurt Berger
James Hiebert
Thomas Witzig
Ajinkya Buradkar
Temeida Graf
Peter Valent
Abhishek A. Mangaonkar
Keith D. Robertson
Matthew T. Howard
Scott H. Kaufmann
Christopher Pin
Martin E. Fernandez-Zapico
Klaus Geissler
Nathalie Droin
Eric Padron
Jing Zhang
Sergey Nikolaev
Mrinal M. Patnaik
author_facet Ryan M. Carr
Denis Vorobyev
Terra Lasho
David L. Marks
Ezequiel J. Tolosa
Alexis Vedder
Luciana L. Almada
Andrey Yurcheko
Ismael Padioleau
Bonnie Alver
Giacomo Coltro
Moritz Binder
Stephanie L. Safgren
Isaac Horn
Xiaona You
Eric Solary
Maria E. Balasis
Kurt Berger
James Hiebert
Thomas Witzig
Ajinkya Buradkar
Temeida Graf
Peter Valent
Abhishek A. Mangaonkar
Keith D. Robertson
Matthew T. Howard
Scott H. Kaufmann
Christopher Pin
Martin E. Fernandez-Zapico
Klaus Geissler
Nathalie Droin
Eric Padron
Jing Zhang
Sergey Nikolaev
Mrinal M. Patnaik
author_sort Ryan M. Carr
title RAS mutations drive proliferative chronic myelomonocytic leukemia via a KMT2A-PLK1 axis
title_short RAS mutations drive proliferative chronic myelomonocytic leukemia via a KMT2A-PLK1 axis
title_full RAS mutations drive proliferative chronic myelomonocytic leukemia via a KMT2A-PLK1 axis
title_fullStr RAS mutations drive proliferative chronic myelomonocytic leukemia via a KMT2A-PLK1 axis
title_full_unstemmed RAS mutations drive proliferative chronic myelomonocytic leukemia via a KMT2A-PLK1 axis
title_sort ras mutations drive proliferative chronic myelomonocytic leukemia via a kmt2a-plk1 axis
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/76c77b395be34b1d8dcd36a45fbde44e
work_keys_str_mv AT ryanmcarr rasmutationsdriveproliferativechronicmyelomonocyticleukemiaviaakmt2aplk1axis
AT denisvorobyev rasmutationsdriveproliferativechronicmyelomonocyticleukemiaviaakmt2aplk1axis
AT terralasho rasmutationsdriveproliferativechronicmyelomonocyticleukemiaviaakmt2aplk1axis
AT davidlmarks rasmutationsdriveproliferativechronicmyelomonocyticleukemiaviaakmt2aplk1axis
AT ezequieljtolosa rasmutationsdriveproliferativechronicmyelomonocyticleukemiaviaakmt2aplk1axis
AT alexisvedder rasmutationsdriveproliferativechronicmyelomonocyticleukemiaviaakmt2aplk1axis
AT lucianalalmada rasmutationsdriveproliferativechronicmyelomonocyticleukemiaviaakmt2aplk1axis
AT andreyyurcheko rasmutationsdriveproliferativechronicmyelomonocyticleukemiaviaakmt2aplk1axis
AT ismaelpadioleau rasmutationsdriveproliferativechronicmyelomonocyticleukemiaviaakmt2aplk1axis
AT bonniealver rasmutationsdriveproliferativechronicmyelomonocyticleukemiaviaakmt2aplk1axis
AT giacomocoltro rasmutationsdriveproliferativechronicmyelomonocyticleukemiaviaakmt2aplk1axis
AT moritzbinder rasmutationsdriveproliferativechronicmyelomonocyticleukemiaviaakmt2aplk1axis
AT stephanielsafgren rasmutationsdriveproliferativechronicmyelomonocyticleukemiaviaakmt2aplk1axis
AT isaachorn rasmutationsdriveproliferativechronicmyelomonocyticleukemiaviaakmt2aplk1axis
AT xiaonayou rasmutationsdriveproliferativechronicmyelomonocyticleukemiaviaakmt2aplk1axis
AT ericsolary rasmutationsdriveproliferativechronicmyelomonocyticleukemiaviaakmt2aplk1axis
AT mariaebalasis rasmutationsdriveproliferativechronicmyelomonocyticleukemiaviaakmt2aplk1axis
AT kurtberger rasmutationsdriveproliferativechronicmyelomonocyticleukemiaviaakmt2aplk1axis
AT jameshiebert rasmutationsdriveproliferativechronicmyelomonocyticleukemiaviaakmt2aplk1axis
AT thomaswitzig rasmutationsdriveproliferativechronicmyelomonocyticleukemiaviaakmt2aplk1axis
AT ajinkyaburadkar rasmutationsdriveproliferativechronicmyelomonocyticleukemiaviaakmt2aplk1axis
AT temeidagraf rasmutationsdriveproliferativechronicmyelomonocyticleukemiaviaakmt2aplk1axis
AT petervalent rasmutationsdriveproliferativechronicmyelomonocyticleukemiaviaakmt2aplk1axis
AT abhishekamangaonkar rasmutationsdriveproliferativechronicmyelomonocyticleukemiaviaakmt2aplk1axis
AT keithdrobertson rasmutationsdriveproliferativechronicmyelomonocyticleukemiaviaakmt2aplk1axis
AT matthewthoward rasmutationsdriveproliferativechronicmyelomonocyticleukemiaviaakmt2aplk1axis
AT scotthkaufmann rasmutationsdriveproliferativechronicmyelomonocyticleukemiaviaakmt2aplk1axis
AT christopherpin rasmutationsdriveproliferativechronicmyelomonocyticleukemiaviaakmt2aplk1axis
AT martinefernandezzapico rasmutationsdriveproliferativechronicmyelomonocyticleukemiaviaakmt2aplk1axis
AT klausgeissler rasmutationsdriveproliferativechronicmyelomonocyticleukemiaviaakmt2aplk1axis
AT nathaliedroin rasmutationsdriveproliferativechronicmyelomonocyticleukemiaviaakmt2aplk1axis
AT ericpadron rasmutationsdriveproliferativechronicmyelomonocyticleukemiaviaakmt2aplk1axis
AT jingzhang rasmutationsdriveproliferativechronicmyelomonocyticleukemiaviaakmt2aplk1axis
AT sergeynikolaev rasmutationsdriveproliferativechronicmyelomonocyticleukemiaviaakmt2aplk1axis
AT mrinalmpatnaik rasmutationsdriveproliferativechronicmyelomonocyticleukemiaviaakmt2aplk1axis
_version_ 1718382925953630208